Evidence map›Paper›PMID 24247010›Full record

ArticleEpigenetics2014

Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis.

Humberto J Ferreira, Holger Heyn, Xavier Garcia del Muro, August Vidal, Sara Larriba, Clara Muñoz, Alberto Villanueva, Manel Esteller

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. HENMT1: an RNA methyltransferase in biology and disease.Journal of Zhejiang University. Science. B · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  8. DNA Methylation Mediates Sperm Quality viaInternational journal of molecular sciences · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Humberto J FerreiraCancer Epigenetics and Biology Program (PEBC); Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain; Programme in Experimental Biology and Biomedicine; Centre for Neurosciences and Cell Biology; University of Coimbra; Coimbra, Portugal.
Holger HeynCancer Epigenetics and Biology Program (PEBC); Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain.
Xavier Garcia del MuroMedical Oncology Department; Catalan Institute of Oncology; Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain.
August VidalPathology Department; University Hospital Bellvitge; Bellvitge Biomedical Research Institute (IDIBEL); Barcelona, Spain.
Sara LarribaHuman Molecular Genetics Group; Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain.
Clara MuñozTranslational Research Laboratory; Catalan Institute of Oncology; Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain.
Alberto VillanuevaTranslational Research Laboratory; Catalan Institute of Oncology; Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain.
Manel EstellerCancer Epigenetics and Biology Program (PEBC); Bellvitge Biomedical Research Institute (IDIBELL); Barcelona, Spain; Department of Physiological Sciences II; School of Medicine; University of Barcelona; Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA); Barcelona, Spain.
Institut d'Investigació Biomédica de Bellvitge · ESInstitut Català d'Ornitologia · ESTranslational Research Institute · AUUniversitat de Barcelona · ESUniversity of Coimbra · PT

Funding

European Research Council 268626
6 · The paper itself

Abstract

Although most cancer research has focused in mRNA, non-coding RNAs are also an essential player in tumorigenesis. In addition to the well-recognized microRNAs, recent studies have also shown that epigenetic silencing by CpG island hypermethylation of other classes of non-coding RNAs, such as transcribed ultraconserved regions (T-UCRs) or small nucleolar RNAs (snoRNAs), also occur in human neoplasia. Herein we have studied the putative existence of epigenetic aberrations in the activity of PIWI proteins, an Argonaute family protein subclass, and the small regulatory PIWI-interacting RNAs (piRNAs) in testicular cancer, as the PIWI/piRNA pathway plays a critical role in male germline development. We have observed the existence of promoter CpG island hypermethylation-associated silencing of PIWIL1, PIWIL2, PIWIL4, and TDRD1 in primary seminoma and non-seminoma testicular tumors, in addition to testicular germ cell tumor cell lines. Most importantly, these epigenetic lesions occur in a context of piRNA downregulation and loss of DNA methylation of the LINE-1 repetitive sequences, one of the target genomic loci where the PIWI/piRNA machinery acts as a caretaker in non-transformed cells.

Indexed as

Epigenesis, GeneticArgonaute ProteinsCarcinogenesisCell Line, TumorCpG IslandsGene ExpressionHumansLong Interspersed Nucleotide ElementsMaleMethylationRNA, Small InterferingTesticular NeoplasmsArgonaute ProteinsRNA, Small InterferingDNA methylationepigeneticsnon-coding RNApiRNAsPIWI proteinstesticular cancer

Identifiers

PMID24247010
PMCPMC3928173
OpenAlexW1972755465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.